The codling moth, Cydia pomonella (L.) (Lepidoptera: Tortricidae), is a key “fruit-feeding” pest of apples and is known for developing resistance to various insecticidal products applied in apple orchards. Laboratory studies were conducted to determine insecticide resistance in codling moth populations collected from various apple orchards in Pennsylvania. In particular, male moths of C. pomonella were collected from commercial and abandoned fruit orchards and were tested for their sensitivity levels to azinphos-methyl and methomyl via adult topical bioassays. Larval sensitivity also was examined for different insecticides (e.g., acetamiprid, novaluron, rynaxypyr) via diet-surface topical bioassays. Adult C. pomonella populations expressed significant differences in their sensitivity to azinphos-methyl and methomyl. Concurrent estimates of azinphos-methyl insecticide effectiveness (i.e., adult topical assays) of moths in monitoring traps showed increased tolerance in individuals captured in commercial orchards rather than in abandoned orchards. Results of larval bioassays showed differences in sensitivity to various insecticide compounds as well as differences between compounds based on the timing of mortality. After the initial assessment, however, all insecticides (except fenpropathrin) exhibited greater toxicity with increasing time.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.